Published in Med Oncol on June 09, 2012
Accelerated partial breast irradiation through brachytherapy for ductal carcinoma in situ: factors influencing utilization and risks of second breast tumors. Breast Cancer Res Treat (2015) 0.76
Geographic variation in the intended choice of adjuvant treatments for women diagnosed with screen-detected breast cancer in Queensland. BMC Public Health (2015) 0.75
Morbidity, mortality, and technical factors of distal pancreatectomy. Am J Surg (2002) 2.03
Arginine deiminase as a novel therapy for prostate cancer induces autophagy and caspase-independent apoptosis. Cancer Res (2009) 1.88
Mitotic rate as a predictor of sentinel lymph node positivity in patients with thin melanomas. Ann Surg Oncol (2005) 1.84
Utility of tumor markers in determining resectability of pancreatic cancer. Arch Surg (2003) 1.58
Modern parathyroid surgery: a cost-benefit analysis of localizing strategies. Arch Surg (2002) 1.54
Influence of physician specialty on treatment recommendations in the multidisciplinary management of soft tissue sarcoma of the extremities. JAMA Surg (2013) 1.47
Experience and attitudes of surgeons toward palliation in cancer. Arch Surg (2005) 1.37
Pancreatic cancer cell lines deficient in argininosuccinate synthetase are sensitive to arginine deprivation by arginine deiminase. Int J Cancer (2008) 1.36
Treatment options for metaplastic breast cancer. ISRN Oncol (2012) 1.30
Inhibition of AKT abrogates chemotherapy-induced NF-kappaB survival mechanisms: implications for therapy in pancreatic cancer. J Am Coll Surg (2004) 1.24
Immediate breast reconstruction after mastectomy increases wound complications: however, initiation of adjuvant chemotherapy is not delayed. Arch Surg (2004) 1.23
Effects of the proteasome inhibitor bortezomib alone and in combination with chemotherapy in the A549 non-small-cell lung cancer cell line. Cancer Chemother Pharmacol (2004) 1.20
Targeting BCL-2 overexpression in various human malignancies through NF-kappaB inhibition by the proteasome inhibitor bortezomib. Cancer Chemother Pharmacol (2005) 1.19
Surgical resident involvement is safe for common elective general surgery procedures. J Am Coll Surg (2011) 1.17
ADI, autophagy and apoptosis: metabolic stress as a therapeutic option for prostate cancer. Autophagy (2009) 1.14
Targeted in vivo imaging of integrin alphavbeta6 with an improved radiotracer and its relevance in a pancreatic tumor model. Cancer Res (2009) 1.14
Interaction of histologic subtype and histologic grade in predicting survival for soft-tissue sarcomas. J Am Coll Surg (2009) 1.10
Effects of the proteasome inhibitor PS-341 on apoptosis and angiogenesis in orthotopic human pancreatic tumor xenografts. Mol Cancer Ther (2002) 1.08
Adjuvant radiation therapy is associated with improved survival for adenoid cystic carcinoma of the breast. J Surg Oncol (2010) 1.08
Racial and ethnic differences in treatment and survival among adults with primary extremity soft-tissue sarcoma. Cancer (2008) 1.06
Hospital readmissions: necessary evil or preventable target for quality improvement. Ann Surg (2014) 1.05
Dermatofibrosarcoma protuberans: reappraisal of wide local excision and impact of inadequate initial treatment. Ann Surg Oncol (2003) 1.04
The role of Akt activation in the response to chemotherapy in pancreatic cancer. Anticancer Res (2010) 1.02
Preoperative evaluation of pancreatic adenocarcinoma. J Hepatobiliary Pancreat Surg (2008) 1.00
Nomogram to predict risk of 30-day morbidity and mortality for patients with disseminated malignancy undergoing surgical intervention. Ann Surg (2011) 0.99
Medullary carcinoma of the breast: a population-based perspective. Med Oncol (2011) 0.98
Reduction in BCL-2 levels by 26S proteasome inhibition with bortezomib is associated with induction of apoptosis in small cell lung cancer. Lung Cancer (2005) 0.98
The diagnostic dilemma of follicular variant of papillary thyroid carcinoma. Surgery (2003) 0.98
Negligible effect of selective preoperative biliary drainage on perioperative resuscitation, morbidity, and mortality in patients undergoing pancreaticoduodenectomy. Arch Surg (2009) 0.97
Diffusion of surgical techniques in early stage breast cancer: variables related to adoption and implementation of sentinel lymph node biopsy. Ann Surg Oncol (2007) 0.95
Schedule-dependent molecular effects of the proteasome inhibitor bortezomib and gemcitabine in pancreatic cancer. J Surg Res (2003) 0.92
Cancer therapy beyond apoptosis: autophagy and anoikis as mechanisms of cell death. J Surg Res (2009) 0.92
P16 expression predicts necrotic response among patients with osteosarcoma receiving neoadjuvant chemotherapy. Hum Pathol (2012) 0.91
Histologic type predicts survival in patients with retroperitoneal soft tissue sarcoma. J Surg Res (2010) 0.90
Proteasome inhibition with PS-341 (bortezomib) in lung cancer therapy. Semin Oncol (2004) 0.90
Multimodality management of a giant cell tumor arising in the proximal sacrum: case report. Spine (Phila Pa 1976) (2002) 0.90
Benefit of postoperative adjuvant therapy for pancreatic cancer: A population-based analysis. Cancer (2009) 0.89
A phase II study of paclitaxel, carboplatin, and radiation with or without surgery for esophageal cancer. J Thorac Oncol (2007) 0.89
BCL-2 functions as an activator of the AKT signaling pathway in pancreatic cancer. J Cell Biochem (2007) 0.89
Predicting survival for well-differentiated liposarcoma: the importance of tumor location. J Surg Res (2011) 0.88
ERK/BCL-2 pathway in the resistance of pancreatic cancer to anoikis. J Surg Res (2008) 0.87
Treatment sequencing strategy for hepatic epithelioid haemangioendothelioma. HPB (Oxford) (2013) 0.87
Rare tumors through the looking glass: an examination of malignant cutaneous adnexal tumors. Arch Dermatol (2011) 0.86
Survival in 12,653 breast cancer patients with extensive axillary lymph node metastasis in the anthracycline era. Med Oncol (2010) 0.86
Sacramento area breast cancer epidemiology study: use of postmastectomy breast reconstruction along the rural-to-urban continuum. Plast Reconstr Surg (2010) 0.86
Surgery in the aged population: surgical oncology. Arch Surg (2003) 0.86
Complete pathologic response to neoadjuvant radiotherapy is predictive of oncological outcome in patients with soft tissue sarcoma. Anticancer Res (2012) 0.86
Influence of specialty and clinical experience on treatment sequencing in the multimodal management of soft tissue extremity sarcoma. Ann Surg Oncol (2011) 0.85
Lack of survival benefit following adjuvant radiation in patients with retroperitoneal sarcoma: a SEER analysis. J Surg Res (2011) 0.85
Preoperative CA 19-9 kinetics as a prognostic variable in radiographically resectable pancreatic adenocarcinoma. J Surg Oncol (2014) 0.85
Contiguous organ resection is safe in patients with retroperitoneal sarcoma: An ACS-NSQIP analysis. J Surg Oncol (2010) 0.85
Comparative morbidity and mortality from cervical or thoracic esophageal anastomoses. J Surg Oncol (2013) 0.84
Surgical management of neurofibromatosis. Surg Oncol Clin N Am (2009) 0.83
A prospective, blinded trial of touch prep analysis versus frozen section for intraoperative evaluation of sentinel lymph nodes in breast cancer. Ann Surg Oncol (2008) 0.83
Effect of generational composition on the surgical workforce. Arch Surg (2008) 0.83
Outcomes for lymph node-positive cutaneous melanoma over two decades. World J Surg (2011) 0.83
TNF-alpha downregulates vascular endothelial Flk-1 expression in human melanoma xenograft model. Am J Physiol Heart Circ Physiol (2002) 0.83
Negligible effect of perioperative epidural analgesia among patients undergoing elective gastric and pancreatic resections. J Gastrointest Surg (2013) 0.82
Perioperative care of the patient with hemophilia undergoing urgent appendectomy. Arch Surg (2007) 0.82
Disparities in the use of radiation therapy in patients with local-regionally advanced breast cancer. Int J Radiat Oncol Biol Phys (2010) 0.81
Upstaging and improved survival of early breast cancer patients after implementation of sentinel node biopsy for axillary staging. Ann Surg Oncol (2006) 0.80
Do radiation use disparities influence survival in patients with advanced breast cancer? Cancer (2011) 0.80
Symptomatic pancreatic polypeptide-secreting tumor of the distal pancreas (PPoma). Int J Gastrointest Cancer (2002) 0.79
Targeting Bcl-2-mediated cell death as a novel therapy in pancreatic cancer. J Surg Res (2010) 0.79
Perioperative outcomes for open distal pancreatectomy: current benchmarks for comparison. J Gastrointest Surg (2011) 0.79
Use of radiotracer for sentinel lymph node mapping in breast cancer optimizes staging independent of site of administration. Clin Nucl Med (2006) 0.79
Controlled tamponade of severe presacral venous hemorrhage: use of a breast implant sizer. Dis Colon Rectum (2002) 0.79
Percutaneous transhepatic portography with intravascular ultrasonography for evaluation of venous involvement of hepatobiliary and pancreatic tumors. J Vasc Interv Radiol (2002) 0.79
Intraoperative jugular venous sampling AIDS detection of an undescended parathyroid adenoma. World J Surg (2006) 0.78
Variable phenotypic expression of identical MYH germline mutations in siblings with attenuated familial adenomatous polyposis. Am Surg (2007) 0.77
A Systematic Review of Emergency Department Use Among Cancer Patients. Cancer Nurs (2016) 0.77
Role of autophagy in apoptotic regulation by Akt in pancreatic cancer. Anticancer Res (2014) 0.77
Factors affecting treatment delivery and outcomes of patients with early-stage pancreatic adenocarcinoma. Pancreas (2011) 0.77
Urban and non-urban disparities in the use of post-mastectomy radiation for breast cancer. Med Oncol (2011) 0.77
Mental health needs and service use in a national sample of adult cancer survivors in the USA: has psychosocial care improved? Psychooncology (2014) 0.77
Extremity soft tissue tumor surgery by surgical specialty: a comparison of case volume among oncology and non-oncology-designated surgeons. J Surg Oncol (2013) 0.77
Quantitative analysis of autophagy using advanced 3D fluorescence microscopy. J Vis Exp (2013) 0.77